Fittingly, we were already able to demonstrate that SMPD1 heterozygous animals show less pronounced hepatic cytokine expression, which in turn might result in stabilization of SMPD1 activity as well as hepatic ceramide content and, therefore, inhibition of monooxygenase downregulation during sepsis [25]. The gene discussed is SMPD1; the disease is Sepsis.